adakveo - crizanlizumab injection(Crizanlizumab)Medication DetailsNovartis Pharmaceuticals CorporationUsage: Adakveo reduces the frequency of vaso-occlusive crises (VOCs) in adults and pediatric patients aged 16 and older with sickle cell disease.Medication Details